It was a noticeable image. Donald Trump stood behind the destination found in the elliptical office on Tuesday, September 30, and tried to create a “major announcement” that was trying to create a “major presentation”, and the CEO of Albert Bourla, PFIZER and pharmaceutical Giant’s covid-199 vaccine sales It was successful. Fierce critics.
The two men carefully avoided eye contact at a 58 -minute press conference except for short moments at the podium. Kennedy said, “Albert and I have a long history of antipathy and antagonism of each other. But I have had tremendous courage.”
Courage, yes. But most of all, it’s a threat to twist your arms. Like colleagues in the drug industry, the pharmaceutical giants in New York did not imagine that one day the most favorable market was not announced in the White House to announce a price cut for US drugs one day. But it was a substance of the agreement sealed with Washington on September 30. It was welcomed by the “huge” victory of the US president and his administration.
81.19%of this article can be read. The rest is only for subscribers.
